QuidelOrtho Corp
Company Stats
- Market Cap
- $722.8M
- as of Sep 30, 2026
- Enterprise Value
- $3.2B
- Shares Outstanding
- 68.6M
- Free Float
- 81.4%
Income Statement
- Revenue
- $2.7B
- Operating Income
- -$919.2M
- Net Income
- -$1.1B
- EBITDA
- -$477.2M
- Non-cash Impairment
- $700.7M
- FCF Margin, 3Y Avg
- -1.6%
- FCF Margin, Worst Year
- -4.0%
Cash Flow
- Free Cash Flow
- -$83.0M
- FCF Yield
- -11.5%
- Owner FCF Yield
- -17.8%
Balance Sheet
- Cash & Equivalents
- $169.8M
- Total Debt
- $2.7B
- Net Debt
- $2.5B
Returns & Capital
- Buyback Yield, 3Y Avg
- 0.3%
- SBC, 3Y Avg
- $46.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $2.7B | -$83.0M | -3.0% |
| FY2024 | $2.8B | -$112.1M | -4.0% |
| FY2023 | $3.0B | $70.9M | 2.4% |
| FY2023 | $3.3B | $744.4M | 22.8% |
| FY2022 | $1.7B | $513.1M | 30.2% |
Annual filing data through FY ended December 28, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back